Mr Simon Oberst
Position: Director of Clinical Development, CRUK Cambridge Centre
Personal home page:
https://uk.linkedin.com/pub/simon-oberst/30/698/b53
PubMed journal articles - click here
My research is in the area of Health Services Research with a special focus on the structure and quallity processes within Comprehensive Cancer Centres in Europe.
Quality; Accreditation; Cancer
Symplectic Elements feed provided by Research Information, University of Cambridge
100 European core quality standards for cancer care and research centres.
Oberst et al. Lancet Oncology, August 2020, https://doi.org/10.1016/S1470-2045(20)30318-1
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks. Kehrloesser, Oberst et al. Molecular Oncology, March 2021. https://doi.org/10.1002/1878-0261.12950
The European Code of Cancer Practice,
Journal of Cancer Policy, Volume 28, 2021,100282,ISSN 2213-5383,
https://doi.org/10.1016/j.jcpo.2021.100282.
Towards a cancer mission in Horizon Europe: recommendation
Anton Berns et al 04 August 2020, Molecular Oncology
https://doi.org/10.1002/1878-0261.12763
Molecular Oncology 2019 https://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.12442 Bridging Research and Clinical Care - the Comprehensive Cancer Centre
Lancet Oncol. 2015 Dec 3. pii: S1470-2045(15)00486-6. doi: 10.1016/S1470-2045(15)00486-6. [Epub ahead of print] Actual costs of cancer drugs in 15 European countries. van Harten WH1, Wind A2, de Paoli P3, Saghatchian M4, Oberst S5.
Participation of Italian Cancer Centres of the ACC in the OECI Accreditation Programme. Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M.
Tumori. 2015;101 Suppl 1:S6-9. doi: 10.5301/tj.5000464. Epub 2015 Dec 30.
PMID: 27098181
